Peer Review History
| Original SubmissionMay 13, 2025 |
|---|
|
Dear Dr. Zeleke, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Cristiana Abbafati, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement. 3. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical. Additional Editor Comments: The present manuscript tackles a prominent and present-day public health concern—barriers to accessing healthcare services among women of reproductive age within sub-Saharan Africa—employing nationally representative DHS datasets and multilevel modeling. The study's objective is praiseworthy and has the potential to contribute to the development of policy. However, the manuscript necessitates substantial revision before publication. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #2: No ********** Reviewer #1: This manuscript tackles an important public-health issue—identifying barriers to healthcare access among reproductive-age women in sub-Saharan Africa (SSA) using pooled DHS data from 2019–2023. The large sample size (N≈134,000), the inclusion of both individual- and community-level variables, and the application of multilevel mixed-effects logistic regression all strengthen its potential impact. However, before this work can be considered for publication, several critical concerns must be addressed: 1. The manuscript does not explain how DHS sampling weights, clustering, and stratification were incorporated (e.g., in Stata’s svy: framework or via robust standard errors). Please specify your approach in the Methods. 2. Multicollinearity is mentioned but actual VIF values are absent. Provide VIFs for all predictors. Include goodness-of-fit metrics (AIC, ∆Deviance) and a brief discussion of residual or influence diagnostics. 3. Several reported CIs are inverted (e.g., AOR=1.23, 95% CI: 1.30–1.15). Please correct all interval bounds and verify consistency across text, tables, and figures. 4. I recommend citing Zhao et al. (2025) “Applied statistical methods for identifying features of heart rate that are associated with nicotine vaping” . Although the outcome differs, that paper presents a robust five‐step workflow.Suggest add�“The five‐step workflow for extracting event‐related features from physiological time‐series data, originally developed by Zhao et al. ,inspired our adaptation of mixed‐effects modeling to detect ‘before/after’ patterns around reported access barriers.” 5.The manuscript contains numerous grammatical errors and non-standard expressions (e.g., “not beg problem,” “were significantly contribute”). Engage a native English speaker or professional editor to ensure clarity. 6. Tables are overly dense (Table 4 in particular). Consider splitting key results into separate tables or adding a forest‐plot figure for the main AORs. Once these issues are adequately addressed, the manuscript will be much stronger and ready for reevaluation. Reviewer #2: The present manuscript addresses a salient and contemporary public health concern—barriers to accessing healthcare services among women of reproductive age in sub-Saharan Africa—utilizing nationally representative DHS datasets and multilevel modeling. The study's objective is praiseworthy and has the potential to contribute to the development of policy. However, in its current state, the manuscript necessitates substantial revision (major) before it can be considered for publication. The following section delineates the issues that should be addressed. 1. The document under review contains a multitude of grammatical inaccuracies, cumbersome phrasing, and a lack of consistent terminology. These issues often hinder the reader's ability to comprehend the original message. It is imperative that all documents undergo a thorough revision. 2. It is imperative that all statistical estimates undergo a thorough review to ensure internal consistency and coherence. 3. The selection of these specific countries is not accompanied by a clear justification, nor is there an explanation for why other countries were excluded (DHS data from 10 sub-Saharan African countries). A rationale must be provided for the inclusion criteria, and the findings must be explicated in terms of their generalizability to the entire SSA region. 4. The definition of the binary outcome "barrier to accessing health care" is not sufficiently explained. The coding scheme and threshold for categorization are not clearly delineated. It is imperative that further elucidation be provided. 5. The multilevel mixed-effects logistic regression model is a methodologicalically sound approach; however, the following issues must be addressed: The presence of inconsistent or implausible AORs and confidence intervals is a concern. The section comparing models is not sufficiently clear. An analysis of the data reveals an overlap and redundancy between text, tables, and figures. It is imperative that all model outputs are thoroughly reviewed and that any transcription errors are rectified. The explanation of random effects statistics must be improved. It is recommended that Figures 1 and 2 be removed or merged into a more informative graphical representation. 6. The discourse is predominantly descriptive, exhibiting a paucity of depth and analytical rigor. It is imperative that the discussion be expanded to encompass the mechanisms underpinning the observed associations, as well as their policy ramifications. It is imperative to differentiate distinctly between individual, household, and system-level barriers. 7. The added value of this study is not articulated with sufficient clarity. 8. It is imperative that the keywords, table, and reference formatting be corrected. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Zeleke, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Could you please carefully revise the manuscript to address all comments raised? Please submit your revised manuscript by Oct 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Helen Howard Staff Editor PLOS ONE Comments from PLOS Editorial Office : We note that one or more reviewers has recommended that you cite specific previously published works. As always, we recommend that you please review and evaluate the requested works to determine whether they are relevant and should be cited. It is not a requirement to cite these works. We appreciate your attention to this request. Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #3: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #3: Yes ********** Reviewer #1: The manuscript is significantly improved, and the majority of my initial concerns have been comprehensively addressed. However, one minor point remains. In the previous review, I suggested a citation that the authors acknowledged as valuable, but it has not yet been incorporated into the manuscript's body or reference list. To potentially strengthen the discussion on limitations and future directions, the authors might consider the following point. The current analysis is comprehensive but relies entirely on self-reported data, which can be subject to recall bias. A forward-looking addition to the discussion could acknowledge this and suggest how future studies might overcome this limitation. For example, research could incorporate objective measures from technologies like wearable devices to assess certain behaviors or states. The study by Zhao et al. (2025) could be cited as an excellent example here, as it demonstrates a complete workflow for processing such complex physiological signals. Ultimately, this is just a suggestion for the authors' consideration, and the decision to incorporate this perspective rests with them. Reviewer #3: Major revisions are necessary, particularly with respect to the clarity of the statistical analyses and the presentation of the data. Line 197: In the health survey data, if a household-level component exists in addition to the individual and community levels, it should usually be considered in the analysis. Are most households contribute to single observations as well as the household variance is non-negligible, and random effects are weak/unidentified? The reason(s) should be explicitly stated. Line 196 -198: The variables included in Model I, Model II, and Model III are to be stated. Alternatively, the table footnotes should indicate the variables that correspond to each model. Line 211- 215: The notations ‘VC’ , ‘V’, 'Variance' should be replaced with the appropriate statistical symbols. Variance null, and the variance model is to be used. Line 214: The standard formula for MOR and not the shortcut version is to be presented. Line 217- 218: The sentence ‘The fixed effects were employed to calculate the correlation between the probability of barriers to obtaining health care access and independent factors at the individual and community levels’ is incorrect and requires revision. Line 223 – 225: The sentence is to be written as a method, not mentioning the results in the method section. Line 231: The variance figures can be omitted. Line 232: The symbol percentage for 69.8 is missing. Table 2: The figures presented should be standardized, e.g., consistent use of commas or decimal points. The same applies to Table 3. Line 244: Typo ‘of.3784967’. The p-value cannot be zero (to use symbol p < ) Line 263-294: It was not clear whether the data written based on Table 4, Table 5, or both. A separate write-up should be provided for each table (Table 4 referring to the association, while Table 5 refers to the determinants of barriers). It is also suggested that the manuscript be proofread thoroughly. Also, please include the crude analyses table prior to adjustment. Table 4 & Table 5: The title not clear. Need to mention clearly or denote how the variables in Table 4 & 5 were selected. Line 252-253: The sentence requires revision. Line 272: In Table 4, there was no data/stem indicating higher than secondary education. Line 273: No information on Table 5 for AOR=1.21, 95% CI: (1.31, 1.41). Line 278: Typo 1.07 (based on Table 5). Line 281: Typo 1.57 (based on Table 4). In Table 5, there was no data on internet utilization. Line 293: Table 4 & Table 5: East Africa is to be used as reference. The references do not conform to the journal’s required format. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Dear Dr. Zeleke, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 24 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Alfredo Luis Fort, M.D., M.Sc., Ph.D. Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: This is an important study using globally accepted data from a number of African countries on an important topic of health care utilization. However, you the authors continue to fail to produce a well-written academic English manuscript, which cannot be understood by any English-speaking reader and does not allow it to be published. I am writing to you asking to PLEASE FIND SOMEBODY WHO WRITES PROPER ACADEMIC ENGLISH before submitting your article again. I have also with extreme detail suggested lots of improvements in the attached file. Also, you cannot use the Discussion to again put each result of each barrier identified and explain it in long detail. You have to find a way to SUMMARIZE the findings so that such section is not too long. I hope you will do that in your next submission, if you want the article published. Thank you. Comments to the Author Reviewer #3: All comments have been addressed Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Partly Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: Yes Reviewer #4: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes Reviewer #4: No ********** Reviewer #3: The statement from the authors 'The household level was not included in the final model since most household contributed one individual and the variance at the household level was insignificant in the preliminary models.' is to be incorporated into the manuscript. Reviewer #4: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No Reviewer #4: Yes: Desalegn Areki Abay ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 3 |
|
Barriers to healthcare access among women in sub-Saharan Africa: A pooled analysis of multi-country DHS data (2019-2023). PONE-D-24-28999R3 Dear Dr. Zeleke, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Alfredo Luis Fort, M.D., M.Sc., Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): This is the THIRD revision you have made to this manuscript. It has improved a lot and there are places where it is now well understood. Unfortunately, there are places where simply the descriptions are not well done or you have not used proper English (unfortunately, you have not found a person who can help you write but also double-check the final writing to ensure everything is well written and understood). We will see if it is possible that PLOS ONE undertakes the final "editing" of the article, because the essence, methods and results are all very valuable in this study. However, if it's not possible, then it would have to be sent to you for a "minor revision" again. If so, PLEASE FIND SOMEBODY WHO CAN FULLY REVIEW YOUR ARTICLE AND ENSURE THAT IT IS WELL WRITTEN IN PROPER ENGLISH AND IS FULLY UNDERSTANDABLE. I have made more suggestions to improve the write-up in the attached file. Thanks.
|
| Formally Accepted |
|
PONE-D-24-28999R3 PLOS One Dear Dr. Zeleke, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Alfredo Luis Fort Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .